Cargando…
Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
BACKGROUND: BAFF (B cell-activating factor) and APRIL (a proliferation-inducing ligand) are members of the tumor necrosis factor family and promote B cell survival and proliferation. We evaluated the correlation between serum concentration of BAFF or APRIL and severity of acute graft-versus-host dis...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208200/ https://www.ncbi.nlm.nih.gov/pubmed/22065972 http://dx.doi.org/10.5045/kjh.2011.46.3.175 |
_version_ | 1782215602563186688 |
---|---|
author | Kim, Jin Seok Kim, Soo-Jeong Cheong, June-Won Kim, Yundeok Hwang, Doh Yu Yoon, Sulhee Jang, Jieun Hyun, Shin Young Min, Yoo Hong |
author_facet | Kim, Jin Seok Kim, Soo-Jeong Cheong, June-Won Kim, Yundeok Hwang, Doh Yu Yoon, Sulhee Jang, Jieun Hyun, Shin Young Min, Yoo Hong |
author_sort | Kim, Jin Seok |
collection | PubMed |
description | BACKGROUND: BAFF (B cell-activating factor) and APRIL (a proliferation-inducing ligand) are members of the tumor necrosis factor family and promote B cell survival and proliferation. We evaluated the correlation between serum concentration of BAFF or APRIL and severity of acute graft-versus-host disease (GVHD). METHODS: Fifteen patients who received allogeneic hematopoietic stem transplantation for leukemia and developed acute GVHD were enrolled. We determined serum concentrations of BAFF and APRIL at the onset of the first clinical manifestation of GVHD by enzyme-linked immunosorbent assay. RESULTS: Nine patients had grade 2 acute GVHD, and 6 had grade 3-4 acute GVHD. The BAFF serum concentration was higher in patients with grade 3-4 acute GVHD (1,093.42 in grade 2 vs. 2,171.99 pg/mL in grade 3-4), although the difference was not significant (P=0.077). However, the ratio of BAFF serum concentration to absolute lymphocyte count (ALC) (BAFF/ALC) was significantly higher in patients with grade 3-4 acute GVHD (P=0.045). The APRIL serum concentration and APRIL/ALC ratio showed similar results (P=0.077 and P=0.013, respectively). CONCLUSION: Patients with grade 3-4 acute GVHD had higher BAFF/ALC and APRIL/ALC ratios than patients with grade 2 acute GVHD. These findings suggest that B cells might play an important role in the development of acute GVHD, and that the BAFF and APRIL concentrations in serum might be significant predictive factors for estimating the severity of acute GVHD. Their clinical significance should be further evaluated in a larger patient population. |
format | Online Article Text |
id | pubmed-3208200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-32082002011-11-07 Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Kim, Jin Seok Kim, Soo-Jeong Cheong, June-Won Kim, Yundeok Hwang, Doh Yu Yoon, Sulhee Jang, Jieun Hyun, Shin Young Min, Yoo Hong Korean J Hematol Original Article BACKGROUND: BAFF (B cell-activating factor) and APRIL (a proliferation-inducing ligand) are members of the tumor necrosis factor family and promote B cell survival and proliferation. We evaluated the correlation between serum concentration of BAFF or APRIL and severity of acute graft-versus-host disease (GVHD). METHODS: Fifteen patients who received allogeneic hematopoietic stem transplantation for leukemia and developed acute GVHD were enrolled. We determined serum concentrations of BAFF and APRIL at the onset of the first clinical manifestation of GVHD by enzyme-linked immunosorbent assay. RESULTS: Nine patients had grade 2 acute GVHD, and 6 had grade 3-4 acute GVHD. The BAFF serum concentration was higher in patients with grade 3-4 acute GVHD (1,093.42 in grade 2 vs. 2,171.99 pg/mL in grade 3-4), although the difference was not significant (P=0.077). However, the ratio of BAFF serum concentration to absolute lymphocyte count (ALC) (BAFF/ALC) was significantly higher in patients with grade 3-4 acute GVHD (P=0.045). The APRIL serum concentration and APRIL/ALC ratio showed similar results (P=0.077 and P=0.013, respectively). CONCLUSION: Patients with grade 3-4 acute GVHD had higher BAFF/ALC and APRIL/ALC ratios than patients with grade 2 acute GVHD. These findings suggest that B cells might play an important role in the development of acute GVHD, and that the BAFF and APRIL concentrations in serum might be significant predictive factors for estimating the severity of acute GVHD. Their clinical significance should be further evaluated in a larger patient population. Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011-09 2011-09-30 /pmc/articles/PMC3208200/ /pubmed/22065972 http://dx.doi.org/10.5045/kjh.2011.46.3.175 Text en © 2011 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Jin Seok Kim, Soo-Jeong Cheong, June-Won Kim, Yundeok Hwang, Doh Yu Yoon, Sulhee Jang, Jieun Hyun, Shin Young Min, Yoo Hong Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
title | Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
title_full | Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
title_fullStr | Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
title_full_unstemmed | Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
title_short | Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
title_sort | clinical significance of b cell-activating factor (baff) and a proliferation-inducing ligand (april) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208200/ https://www.ncbi.nlm.nih.gov/pubmed/22065972 http://dx.doi.org/10.5045/kjh.2011.46.3.175 |
work_keys_str_mv | AT kimjinseok clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT kimsoojeong clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT cheongjunewon clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT kimyundeok clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT hwangdohyu clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT yoonsulhee clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT jangjieun clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT hyunshinyoung clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation AT minyoohong clinicalsignificanceofbcellactivatingfactorbaffandaproliferationinducingligandaprilinacutegraftversushostdiseaseafterallogeneichematopoieticstemcelltransplantation |